Healthcare -
Biotechnology - NASDAQ - US
$ 2.85
-5.94 %
$ 182 M
Market Cap
-2.48
P/E
LRMR - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities LRMR - Larimar Therapeutics, Inc.
33.4 M
LAST VALUE
17.47%
2 YEAR CAGR
46.97%
5 YEAR CAGR
113.46%
10 YEAR CAGR